Showing 38,141 - 38,160 results of 101,126 for search '(( 5 mm decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.74s Refine Results
  1. 38141

    A parallel randomized controlled trial examining the effects of rhythmic sensory stimulation on fibromyalgia symptoms by Thenille Braun Janzen (6295259)

    Published 2019
    “…One group received vibrotactile stimulation from a continuous sine wave single-frequency stimulation (40 Hz) for 30 minutes, five days per week, over five weeks, concomitant with usual care. …”
  2. 38142
  3. 38143

    The changing trends of <i>f</i><sub><i>i</i></sub>, <i>i</i> ∈ {1, 2, 3, 4} with <i>v</i> for the Moran process (first row) and the Wright-Fisher process (second row) when <i>u</i>... by Yanling Zhang (6561)

    Published 2018
    “…For all <i>r</i>, The curve of <i>f</i><sub>4</sub> with <i>v</i> (fourth column) has an increasing trend with a small perturbation near <i>v</i> = 0.01. …”
  4. 38144
  5. 38145

    Personalized Prediction of Lifetime Benefits with Statin Therapy for Asymptomatic Individuals: A Modeling Study by Bart S. Ferket (107294)

    Published 2012
    “…Twenty-five percent of participants with a low SCORE risk achieved equal or larger gains in CVD-free life expectancy than the median gain in participants with a high SCORE risk.…”
  6. 38146

    <b>Warming alters plankton body-size distributions in a large field experiment</b> by Dania Albini (20288463)

    Published 2024
    “…We found a nonlinear decrease in the overall mean body size of zooplankton with warming, with a 57% reduction at +8°C. …”
  7. 38147
  8. 38148
  9. 38149
  10. 38150

    Evaluation of biological and enzymatic quorum quencher coating additives to reduce biocorrosion of steel by Siqian Huang (6707825)

    Published 2019
    “…We also evaluated a previously engineered, extremely stable, non-biocidal enzyme known to interfere in bacterial signaling, <i>Sso</i>Pox (a quorum quenching lactonase). …”
  11. 38151

    Amide Proton Transfer Imaging of Diffuse Gliomas: Effect of Saturation Pulse Length in Parallel Transmission-Based Technique - Fig 2 by Osamu Togao (470739)

    Published 2016
    “…MTR<sub>asym</sub> (<b>A</b>) of tumor was decreased with the saturation length in lower frequency range (1–2 ppm), but equivalent at 3.5 ppm. …”
  12. 38152
  13. 38153
  14. 38154

    Paraquat induces <i>hsp-6</i> and its reporter in a ROS–dependent manner. by Eva D. Runkel (389726)

    Published 2013
    “…<p>A. Quantitative analysis (by qRT-PCR) of endogenous <i>hsp-6</i> mRNA in wild type (N2) worms exposed to 0.5 mM paraquat from early L3 stage on for 4 h, 24 h and 30 h, presented as fold induction. …”
  15. 38155

    Process flow diagram of the gasification system. by Fidel Vallejo (17015024)

    Published 2023
    “…HTC was conducted for one hour at 220°C in a 5 L reactor, followed by gasification in a hybrid porous medium gasifier. …”
  16. 38156

    Response surface for hydrogen content. by Fidel Vallejo (17015024)

    Published 2023
    “…HTC was conducted for one hour at 220°C in a 5 L reactor, followed by gasification in a hybrid porous medium gasifier. …”
  17. 38157

    Variable levels in the experimental design. by Fidel Vallejo (17015024)

    Published 2023
    “…HTC was conducted for one hour at 220°C in a 5 L reactor, followed by gasification in a hybrid porous medium gasifier. …”
  18. 38158

    Experimental setup for gasification system. by Fidel Vallejo (17015024)

    Published 2023
    “…HTC was conducted for one hour at 220°C in a 5 L reactor, followed by gasification in a hybrid porous medium gasifier. …”
  19. 38159

    Description of the gasification reactor. by Fidel Vallejo (17015024)

    Published 2023
    “…HTC was conducted for one hour at 220°C in a 5 L reactor, followed by gasification in a hybrid porous medium gasifier. …”
  20. 38160

    Bleeding Risk and Mortality of Edoxaban: A Pooled Meta-Analysis of Randomized Controlled Trials by Shuang Li (146392)

    Published 2014
    “…Overall, edoxaban was associated with a significant decrease in major or clinically relevant nonmajor bleeding events [risk ratio (RR) 0.78, 95% confidence interval (CI) 0.74 to 0.82, p<0.001] and any bleeding events [RR 0.82, 95% CI 0.79 to 0.85, p<0.001]. …”